The expression of androgen receptor variants (AR-Vs) is associated with the development of advanced castration-resistant prostate cancers (CRPCs), while prostate cancer stem cells (PCSCs) have been evaluated as the most dangerous malignant seeding cells. Here, AR is linked to prostate carcinoma.